Depreciation of Whitehawk Therapeutics, Inc. from 31 Mar 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Whitehawk Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2016 to 30 Sep 2025.
  • Whitehawk Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $5,600, a 88% decline year-over-year.
  • Whitehawk Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $131,600, a 41% decline year-over-year.
  • Whitehawk Therapeutics, Inc. annual Depreciation for 2024 was $200,000, unchanged from 2023.
  • Whitehawk Therapeutics, Inc. annual Depreciation for 2023 was $200,000, a 100% increase from 2022.
  • Whitehawk Therapeutics, Inc. annual Depreciation for 2022 was $100,000.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Whitehawk Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $131,600 $5,600 -$41,100 -88% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $172,700 $15,300 -$34,300 -69% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $207,000 $57,000 +$7,000 +14% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $200,000 $53,700 -$21,300 -28% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $221,300 $46,700 +$2,700 +6.1% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $218,600 $49,600 +$6,600 +15% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $212,000 $50,000 +$12,000 +32% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $200,000 $75,000 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $44,000 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $43,000 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $38,000 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2021 $16,780 +$1,678 +11% 01 Jan 2021 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q1 2020 $15,102 +$2,112 +16% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $12,990 +$460 +3.7% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $12,530 -$1,126 -8.2% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $13,656 -$2,829 -17% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $16,485 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1

Whitehawk Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $200,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $200,000 +$100,000 +100% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $100,000 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024 2023 FY
2020 $61,482 -$15,019 -20% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2021 2020 FY
2019 $76,501 +$29,815 +64% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $46,686 -$4,582 -8.9% 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY
2017 $51,268 -$18,405 -26% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $69,673 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.